Supernus Pharmaceuticals, Inc. (SUPN)
50.80
+0.59
(+1.18%)
USD |
NASDAQ |
Mar 17, 16:00
50.80
0.00 (0.00%)
After-Hours: 17:02
Supernus Pharmaceuticals Total Liabilities (Quarterly) : 552.44M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Biogen, Inc. | 11.18B |
| BridgeBio Pharma, Inc. | 3.013B |
| Corcept Therapeutics, Inc. | 190.22M |
| Catalyst Pharmaceuticals, Inc. | 152.54M |
| Cytokinetics, Inc. | 2.084B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.614B |
| Shareholders Equity (Quarterly) | 1.062B |
| Debt to Equity Ratio | 0.0386 |
| Current Ratio | 1.905 |
| Net Debt Paydown Yield | -0.02% |